These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 24016317)

  • 1. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.
    Tang SX; Yi JJ; Calkins ME; Whinna DA; Kohler CG; Souders MC; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Psychol Med; 2014 Apr; 44(6):1267-77. PubMed ID: 24016317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trajectories of psychiatric diagnoses and medication usage in youth with 22q11.2 deletion syndrome: a 9-year longitudinal study.
    Kates WR; Mariano MA; Antshel KM; Chandra S; Gamble H; Giordano M; MacMaster E; Mattar M; St Fleur D; Faraone SV; Fremont WP
    Psychol Med; 2019 Aug; 49(11):1914-1922. PubMed ID: 30226117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
    Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
    Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.
    Weisman O; Guri Y; Gur RE; McDonald-McGinn DM; Calkins ME; Tang SX; Emanuel B; Zackai EH; Eliez S; Schneider M; Schaer M; Kates WR; Antshel KM; Fremont W; Shashi V; Hooper SR; Armando M; Vicari S; Pontillo M; Kushan L; Jalbrzikowski M; Bearden CE; Cubells JF; Ousley OY; Walker EF; Simon TJ; Stoddard J; Niendam TA; van den Bree MBM; Gothelf D;
    Schizophr Bull; 2017 Sep; 43(5):1079-1089. PubMed ID: 28204757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
    Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.
    Schneider M; Debbané M; Bassett AS; Chow EW; Fung WL; van den Bree M; Owen M; Murphy KC; Niarchou M; Kates WR; Antshel KM; Fremont W; McDonald-McGinn DM; Gur RE; Zackai EH; Vorstman J; Duijff SN; Klaassen PW; Swillen A; Gothelf D; Green T; Weizman A; Van Amelsvoort T; Evers L; Boot E; Shashi V; Hooper SR; Bearden CE; Jalbrzikowski M; Armando M; Vicari S; Murphy DG; Ousley O; Campbell LE; Simon TJ; Eliez S;
    Am J Psychiatry; 2014 Jun; 171(6):627-39. PubMed ID: 24577245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome.
    Niarchou M; Chawner SJRA; Fiksinski A; Vorstman JAS; Maeder J; Schneider M; Eliez S; Armando M; Pontillo M; Vicari S; McDonald-McGinn DM; Emanuel BS; Zackai EH; Bearden CE; Shashi V; Hooper SR; Owen MJ; Gur RE; Wray NR; van den Bree MBM; Thapar A;
    Schizophr Res; 2019 Feb; 204():320-325. PubMed ID: 30093352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome.
    Jolin EM; Weller RA; Weller EB
    J Affect Disord; 2012 Feb; 136(3):222-8. PubMed ID: 21215459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
    Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
    Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
    Stoddard J; Niendam T; Hendren R; Carter C; Simon TJ
    Schizophr Res; 2010 May; 118(1-3):118-21. PubMed ID: 20056393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome.
    Schneider M; Armando M; Schultze-Lutter F; Pontillo M; Vicari S; Debbané M; Eliez S
    Schizophr Res; 2019 Apr; 206():386-393. PubMed ID: 30414720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.
    Tang SX; Yi JJ; Moore TM; Calkins ME; Kohler CG; Whinna DA; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Bilker WB; Gur RC; Gur RE
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):991-1000.e2. PubMed ID: 25151422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning.
    Armando M; Lin A; Pontillo M; Vicari S
    Psychiatry Res; 2017 Aug; 254():238-243. PubMed ID: 28477546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.
    Yi JJ; Tang SX; McDonald-McGinn DM; Calkins ME; Whinna DA; Souders MC; Zackai EH; Goldmuntz E; Gaynor JW; Gur RC; Emanuel BS; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2014 Mar; 165B(2):137-47. PubMed ID: 24265253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study.
    Gothelf D; Schneider M; Green T; Debbané M; Frisch A; Glaser B; Zilkha H; Schaer M; Weizman A; Eliez S
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1192-1203.e3. PubMed ID: 24157393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affective disorders and other psychiatric diagnoses in children and adolescents with 22q11.2 Deletion Syndrome.
    Jolin EM; Weller RA; Jessani NR; Zackai EH; McDonald-McGinn DM; Weller EB
    J Affect Disord; 2009 Dec; 119(1-3):177-80. PubMed ID: 19269692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of psychiatric comorbidity and cognitive deficit on function in 22q11.2 deletion syndrome.
    Yi JJ; Calkins ME; Tang SX; Kohler CG; McDonald-McGinn DM; Zackai EH; Savitt AP; Bilker WB; Whinna DA; Souders MC; Emanuel BS; Gur RC; Gur RE
    J Clin Psychiatry; 2015 Oct; 76(10):e1262-70. PubMed ID: 26528648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Cognition and Psychosis in Young Adults With 22q11.2 Deletion Syndrome.
    Antshel KM; Fremont W; Ramanathan S; Kates WR
    Schizophr Bull; 2017 Jul; 43(4):833-842. PubMed ID: 27798222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis.
    Goldenberg PC; Calkins ME; Richard J; McDonald-McGinn D; Zackai E; Mitra N; Emanuel B; Devoto M; Borgmann-Winter K; Kohler C; Conroy CG; Gur RC; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jan; 159B(1):87-93. PubMed ID: 22170773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions.
    Shashi V; Veerapandiyan A; Schoch K; Kwapil T; Keshavan M; Ip E; Hooper S
    J Intellect Disabil Res; 2012 Sep; 56(9):865-78. PubMed ID: 21883601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.